India's Divi's Laboratories reported first-quarter profit below estimates on Wednesday, as manufacturers producing generic ...

Welcome to the Cipla Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...

In conclusion, several Nifty 50 stocks, including Cipla, Sun Pharma and Infosys, experienced declines in Wednesday's trading ...

The US government has long sought to shift pharmaceutical manufacturing back to domestic soil, citing both economic and ...

Eris Lifesciences is using its growing insulin business to position itself as a serious contender in India’s fast-expanding ...

Proposed merger anticipated to close in 2025 As part of the proposed merger, Pulmatrix currently intends to divest its assets including its ...

Markets open flat ahead of RBI MPC decision; watch for updates on repo rate, inflation, and key stock movers today.

Broad cap indices saw higher selling pressure. The Nifty midcap 100 index was down 0.54 per cent and Nifty smallcap 100 index ...

Eris Lifesciences plans to lead in generic semaglutide drugs. The patent for Novo Nordisk's drug expires in India in March ...

LASCO Distributors reported a 15.3 per cent drop in net profit to $304 million for Q1 2025/26, with revenues dipping slightly ...

The market ended lower for the second consecutive session on Wednesday amid volatility after the Reserve Bank of India (RBI) kept key interest rates unchanged and maintained a 'neutral' stance.

The RBI Monetary Policy Committee, led by Governor Sanjay Malhotra, maintained repo rates at 5.5%. Following this, the BSE ...